United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Novo Nordisk to acquire Cardior Pharmaceuticals to expand cardiovascular portfolio In a significant move within the pharmaceutical industry, Novo Nordisk has agreed to acquire Cardior Pharmaceuticals for up… byPallavi MadhirajuMarch 25, 2024